Clinical Trials Update: Dec. 15, 2006
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
223061
Drug companies could soon make more experimental drugs available for a fee to more patients with serious or life-threatening diseases that have no approved treatments, under revised rules the U.S. Food and Drug Administration proposed on Monday.
534985
Early results from a new study of GlaxoSmithKline Plc's diabetes drug Avandia showed no difference in the risk of heart problems between patients taking the controversial drug and those who took other diabetes drugs, researchers said on Tuesday.
62269
A New Jersey court awards damages to Idaho couple in Vioxx case.Plus: SEC and OSC file complaints against former Nortel execs... Bush administration says it's fish farming season... and more.
438501
Here's what a newly approved drug looks like.
31944
Pharmaceutical giant Pfizer Inc. will  announce plans for a large-scale clinical trial of the ability  of blockbuster drug Celebrex to prevent heart attacks and  strokes in patients with cardiovascular disease, the Wall  Street Journal reported on Monday.
116025
WASHINGTON The Food and Drug Administration has ordered a sweeping review of studies involving prescription painkillers like Celebrex and Bextra.
500493
SATURDAY, Jan. 29 (HealthDayNews) -- A new drug that targets pancreatic cancer in two ways is being tested by oncologists at the University of Southern California/Norris Comprehensive Cancer Center.
478882
Pfizer (PFE) said Friday that is has received new information about the cardiovascular safety of its popular arthritis drug Celebrex, based on an analysis of a long-term cancer trial.
122956
Many clinical cancer trials are not published in order to keep industry secrets. A British cancer research group calls for all studies to be published -- even those with marginal results -- so doctors are not misled.
621066
Two newly published studies in the September 17, 2004 issue of Science give rise to the possibility of developing drug therapies that target eosinophils, white blood cells long known to be associated with the asthma.
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
403859
TUESDAY, Oct. 5 (HealthDayNews) -- A trial for what appeared to be a promising new therapy for Parkinson's disease has been halted, although researchers haven't given up hope that the drug will one day prove useful.
275372
Drugmakers are working on experimental diabetes drugs using a novel mechanism to help flush excess blood sugar out of the body, according to results of small studies presented at a medical meeting on Sunday.
519863
The company faces a pivotal clinical trial.
273621
Pfizer Inc&#39;s experimental oral  biotechnology drug axitinib demonstrated substantial anti-tumor  activity in patients with advanced thyroid cancer in a small,  mid-stage clinical trial, according to data released at a major  cancer meeting on Saturday.
370141
FRIDAY, Jan. 11 (HealthDay News) -- Therapeutic vaccines to fight ovarian and breast cancer are in the first stage of clinical trials to determine their safety and effectiveness, researchers report.